Expo 2030 Riyadh and Mohammed Al Habib Real Estate Company Sign a 3.2 billion SAR Joint Venture Agreement to Develop and Deliver Expo Village
14.9.2026 12:42:00 EEST | Business Wire | Press release
Expo 2030 Riyadh and Mohammed Al Habib Real Estate Company (MAHR) have signed a 3.2 billion SAR joint venture agreement for the development and delivery of the Expo Village, the residential community for Expo 2030 Riyadh. The agreement represents the first joint venture milestone for Expo 2030 Riyadh and reinforces itscommitment to partnering with the private sector to unlock economic opportunities and create lasting value, both in the lead-up to the Expo and well beyond the event itself.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260914576734/en/
Expo 2030 Riyadh and Mohammed Al Habib Real Estate Company (MAHR) have signed a 3.2 billion SAR joint venture agreement for the development and delivery of the Expo Village, the residential community for Expo 2030 Riyadh
The Expo Village will provide purpose-built accommodation for Official Participants and delegations within a fully integrated sustainable district. Designed to offer a convenient and comfortable living environment, the Village will support international participants throughout their stay and enable the smooth operation of their presence at Expo 2030 Riyadh. Featuring around 2,300 residential apartments with capacity to accommodate around 5,500 residents, the development will be supported by a range of retail and dining spaces, amenities, services and operational facilities, and will provide optimal connectivity to the Expo 2030 Riyadh site through the Expo metro station, King Khalid International Airport and Riyadh’s wider transport network.
The agreement was signed by Talal Al-Marri, Chief Executive Officer of Expo 2030 Riyadh, and Abdullah Mohammed Al Habib, Chief Executive Officer of Mohammed Al Habib Real Estate Company, at the Expo 2030 Riyadh site, where development and construction works continue to advance at pace.
The signing took place in the presence of Saad Al-Kroud, Head of Local Real Estate Investments at the Public Investment Fund, and Chairman of the Executive Committee of the Board of Directors of Expo 2030 Riyadh Company.
Commenting on the announcement, Talal Al-Marri, CEO of Expo 2030 Riyadh, said: “The Expo Village represents an important step in the delivery of Expo 2030 Riyadh and reflects our approach to building effective partnerships with the private sector, leveraging its expertise, capabilities and investment as a strategic partner in delivery. As implementation accelerates and work progresses across the Expo 2030 Riyadh site, we continue to develop the infrastructure, services and facilities required to meet the needs of official participants.
Through this agreement with Mohammad Al Habib Real Estate Company, the Expo Village is moving into an advanced stage of delivery, following the completion of design and site preparation works, paving the way for construction to begin in line with the approved schedule. The Expo Village will provide international participants with a high-quality, integrated residential environment during the event, before transitioning into a permanent residential community after Expo. In doing so, it will contribute to the long-term legacy of Expo 2030 Riyadh and create lasting economic and urban value for the city of Riyadh.”
Abdullah Mohammed Al Habib, CEO of MAHR,said: “This agreement represents a major milestone for Mohammad Al Habib Real Estate. We are proud to support the preparedness of Expo 2030 Riyadh and to draw on over fifty years of experience to create a comprehensive residential project that matches the significance of this international event.”
He added: "We see this project as a unique addition to Expo 2030 Riyadh, offering an experience deserving of the city and its visitors. It is based on a real estate development approach focused on high standards in planning, execution, and operations, ensuring lasting value that continues long after the exhibition ends.”
Designed from the outset for long-term use, the Expo Village will transition into an integrated residential community. Its mix of homes, retail, dining, leisure and community facilities, together with landscaped public spaces and pedestrian friendly streets, will support an active neighbourhood within the wider development of northern Riyadh. The development has been designed to incorporate climate-responsive principles and efficient building systems, to support long-term environmental and operational performance.
The Expo Village is the first residential development for which Expo 2030 Riyadh has signed a joint venture agreement, with further residential developments expected to follow as part of the Expo’s Legacy phase.
Expo 2030 Riyadh will take place from 1 October 2030 to 31 March 2031 under the theme “Foresight for Tomorrow.” The six-month World Expo is expected to bring together 197 Official Participants and is expected to welcome 42 million visits.
About Expo 2030 Riyadh
Running from 1 October 2030 to 31 March 2031, Expo 2030 Riyadh will be among the most ambitious World Expos ever conceived with a 6 million square meter site that will bring together 197 Official Participants and is expected to welcome 42 million visits across 5 distinct districts.
Held under the theme “Foresight for Tomorrow,” and hosted in Riyadh - a city of action and ambition - Expo 2030 Riyadh will provide a platform for participants to exchange ideas, shape solutions, and build partnerships that drive real impact, address global challenges, and unlock new opportunities. The World Expo will feature immersive cultural zones, daily activations, and AI-powered interactions, blending traditional Saudi hospitality with cutting-edge technology. Following the six-month event, the Expo site will evolve into a Global Village, continuing to attract visitors and contribute to Riyadh’s dynamic urban landscape.
For more information, please visit: https://www.expo2030riyadh.sa/en/
About Mohammed Al Habib Real Estate Company
Mohammad Al Habib Real Estate Company is a prominent developer in Saudi Arabia, founded in 1972, with more than fifty years of experience. Over time, it has expanded to include a comprehensive ecosystem that spans development, investment, management, and operation of real estate projects.
Throughout its journey, the company has completed a variety of projects including residential communities and commercial destinations. These developments are known for their high-quality planning and execution, enhanced by comprehensive facilities and services. They meet market needs and contribute to communities and destinations that deliver lasting, sustainable value.
For more information, please visit: alhabibinv.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20260914576734/en/
Contacts
For media inquiries, please contact media@expo2030riyadh.sa
For media inquiries, please contact marketing@alhabibinv.com,
pr@bernaysmedia.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Final MINT Study Results Strengthen Real-World Evidence for Mogamulizumab (Poteligeo ® ) in Patients With Mycosis Fungoides and Sézary Syndrome12.10.2026 09:00:00 EEST | Press release
Kyowa Kirin International plc, a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), today announced final results from the German MINT study evaluating mogamulizumab in patients with mycosis fungoides (MF) and Sézary Syndrome (SS). Presented at the European Organisation for Research and Treatment of Cancer Cutaneous Lymphoma Tumour Group (EORTC-CLTG) Annual Meeting 2026 in Berlin, Germany, the findings represent one of the largest real-world evaluations of mogamulizumab in Germany and add to the growing body of evidence supporting its use in routine clinical practice.1-3 Conducted as a company-sponsored, multicentric, non-interventional, combined retro-prospective real-world study across 18 centres throughout Germany, MINT brought together cutaneous T‑cell lymphoma (CTCL) specialists to evaluate treatment outcomes with mogamulizumab in a real-world setting, with time-to-next-treatment (TTNT) as the study’s primary endpoint.1 The study captured a broad and heterog
Megaport Expands Global Automated Infrastructure Platform Into Portugal12.10.2026 09:00:00 EEST | Press release
Megaport Limited (ASX: MP1) (“Megaport”), a leading global automated infrastructure platform, today announced the launch of its services in Portugal, expanding its European footprint and enabling enterprises and service providers in the region to connect instantly to the world’s leading cloud, network, and data center providers. With new on-ramps in Lisbon, customers in Portugal can now access Megaport’s automated infrastructure platform as well as more than 1,200 enabled data centers worldwide. This launch gives enterprises, MSPs, and carriers private, high-performance compute, network, and storage, as well as on-demand regional interconnection with scalable bandwidth. With Portugal’s data center market projected to reach US$3.09 billion by 2030 as well as Lisbon’s proximity to major submarine cable landings, the strengthening global connectivity hub is a natural next step for Megaport. “Portugal’s digital economy is rapidly growing, and infrastructure is at the heart of that transfor
Filippo Fagnani from Quanta System Receives the EAU Award for Significant Contribution to Endourology at ICE 202610.10.2026 19:09:00 EEST | Press release
Filippo Fagnani, Marketing & Scientific Director of Quanta System’s Surgical Division, has been honoured with the Award for Significant Contribution to Endourology at ICE26, the International Conference on Endourology organised by the EAU Endourology Section. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261010101303/en/ Filippo Fagnani receiving the prize with Olivier Traxer and Professor Bhaskar Somani. The recognition celebrates more than two decades of professional commitment to laser technology and a career built around a clear ambition: to translate the needs of urologists into increasingly precise, flexible and useful technologies, with the ultimate goal of supporting patient safety and better surgical outcomes. “I have always believed that technology should make the surgeon’s work more precise, more flexible and, most importantly, safer for the patient. My goal has never been to develop technology for its own sake,
Emdoor Information Marks 18 Years of Rugged Computing Excellence with Vertically Integrated Capabilities10.10.2026 13:30:00 EEST | Press release
As industrial automation, smart manufacturing, and field operations increasingly depend on mission-critical mobile computing, global demand for reliable rugged tablets, rugged laptops, and rugged handhelds continues to accelerate. Emdoor Information, a publicly listed company on China’s A-share main board since 2023 and an 18-year veteran in rugged computing, has established itself as a rugged computing solutions provider for industrial customers worldwide. Founded in 2008, the company delivers sustained growth, world-class manufacturing, resilient supply chains, full-stack R&D, and comprehensive lifecycle services. Its rugged computing products and industrial customers now span North America, Latin America, Europe, and Asia-Pacific, serving sectors such as public utilities, intelligent manufacturing, warehouse management, transportation, energy industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261010564561/en/ Rugged
Vertex to Present New Data on ALYFTREK ® at the North American Cystic Fibrosis Conference9.10.2026 20:15:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine pancreatic function represent a profound shift in how we understand the benefits of treating cystic fibrosis in its earliest stages,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Devel
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom